Loading resource…

KDIGO
The document presents recommendations and practice points for medication management in CKD, with a focused update organized around major drug classes. It includes evidence reviews and discussion of clinical outcomes, including finerenone use in people with and without diabetes. The guideline also describes its development methods, evidence certainty, and recommendation grading. The document is marked as a draft for public review and feedback and states that it should not be used for other purposes.
No account needed